<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD002760" GROUP_ID="SYMPT" ID="115699123012080383" MERGED_FROM="" MODIFIED="2011-02-08 11:50:15 +0100" MODIFIED_BY="Jessica Thomas" REVIEW_NO="15" REVMAN_SUB_VERSION="5.0.11" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="11.0">
<COVER_SHEET MODIFIED="2011-02-08 11:50:15 +0100" MODIFIED_BY="Jessica Thomas">
<TITLE MODIFIED="2008-05-28 13:42:49 +0100" MODIFIED_BY="Jessica Thomas">Single dose oral dihydrocodeine for acute postoperative pain</TITLE>
<CONTACT MODIFIED="2011-02-08 11:50:15 +0100" MODIFIED_BY="Jessica Thomas"><PERSON ID="A54BF87E82E26AA201B8424EDA13C250" ROLE="AUTHOR"><PREFIX>Mrs</PREFIX><FIRST_NAME>Maura</FIRST_NAME><LAST_NAME>Moore</LAST_NAME><EMAIL_1>maura.moore@pru.ox.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics)</DEPARTMENT><ORGANISATION>University of Oxford</ORGANISATION><ADDRESS_1>Pain Research Unit</ADDRESS_1><ADDRESS_2>Churchill Hospital</ADDRESS_2><CITY>Oxford</CITY><ZIP>OX3 7LJ</ZIP><REGION>Oxfordshire</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1865 225405</PHONE_1><FAX_1>+44 1865 225402</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2011-02-08 11:50:15 +0100" MODIFIED_BY="Jessica Thomas"><PERSON ID="7899" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>R Andrew</FIRST_NAME><LAST_NAME>Moore</LAST_NAME><SUFFIX>DSc</SUFFIX><POSITION>Research Director</POSITION><EMAIL_1>andrew.moore@pru.ox.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics)</DEPARTMENT><ORGANISATION>University of Oxford</ORGANISATION><ADDRESS_1>Pain Research Unit</ADDRESS_1><ADDRESS_2>Churchill Hospital</ADDRESS_2><CITY>Oxford</CITY><ZIP>OX3 7LJ</ZIP><REGION>Oxfordshire</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1865 225401</PHONE_1><FAX_1>+44 1865 225402</FAX_1></ADDRESS></PERSON><PERSON ID="4D32DC6982E26AA20145240A91884D05" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Jayne</FIRST_NAME><LAST_NAME>Edwards</LAST_NAME><ADDRESS><DEPARTMENT>Training Team</DEPARTMENT><ORGANISATION>UK Cochrane Centre</ORGANISATION><ADDRESS_1>National Institute for Health Research</ADDRESS_1><ADDRESS_2>Summertown Pavilion, Middle Way</ADDRESS_2><CITY>Oxford</CITY><ZIP>OX2 7LG</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1865 516300</PHONE_1><FAX_1>+44 1865 516311</FAX_1></ADDRESS></PERSON><PERSON ID="5475F46C82E26AA20187B79619319C6E" ROLE="AUTHOR"><FIRST_NAME>Sheena</FIRST_NAME><LAST_NAME>Derry</LAST_NAME><POSITION>Senior Research Officer</POSITION><EMAIL_1>sheena.derry@pru.ox.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics)</DEPARTMENT><ORGANISATION>University of Oxford</ORGANISATION><ADDRESS_1>Churchill Hospital</ADDRESS_1><CITY>Oxford</CITY><ZIP>OX3 7LJ</ZIP><REGION>Oxfordshire</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1865 225405</PHONE_1></ADDRESS></PERSON><PERSON ID="7877" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Henry</FIRST_NAME><MIDDLE_INITIALS>J</MIDDLE_INITIALS><LAST_NAME>McQuay</LAST_NAME><POSITION>Professor of Pain Research</POSITION><EMAIL_1>henry.mcquay@pru.ox.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics)</DEPARTMENT><ORGANISATION>University of Oxford</ORGANISATION><ADDRESS_1>West Wing (Level 6)</ADDRESS_1><ADDRESS_2>John Radcliffe Hospital</ADDRESS_2><CITY>Oxford</CITY><ZIP>OX3 9DU</ZIP><REGION>Oxfordshire</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1865 231515</PHONE_1><PHONE_2>+44 1865 851138</PHONE_2><FAX_1>+44 1865 223844</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2008-06-05 17:05:05 +0100" MODIFIED_BY="Jessica R Thomas">
<UP_TO_DATE>
<DATE DAY="12" MONTH="12" YEAR="2007"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="12" MONTH="12" YEAR="2007"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="1" YEAR="2013"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2000"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2000"/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="2000"/>
</DATES>
<WHATS_NEW MODIFIED="2011-02-08 11:50:15 +0100" MODIFIED_BY="Jessica Thomas"><WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2011-02-08 11:50:15 +0100" MODIFIED_BY="Jessica Thomas"><DATE DAY="8" MONTH="2" YEAR="2011"/><DESCRIPTION><P>Contact details updated.</P></DESCRIPTION></WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="STABLE" MODIFIED="2008-06-05 17:04:46 +0100" MODIFIED_BY="Jessica R Thomas">
<DATE DAY="5" MONTH="6" YEAR="2008"/>
<DESCRIPTION>
<P>The review authors consider that additional relevant studies are unlikely to be conducted, and that further updates of this review are unnecessary.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>

</WHATS_NEW>
<HISTORY MODIFIED="2011-02-08 11:50:15 +0100" MODIFIED_BY="Jessica Thomas"><WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2011-02-08 11:50:15 +0100" MODIFIED_BY="Jessica Thomas"><DATE DAY="24" MONTH="9" YEAR="2010"/><DESCRIPTION><P>Contact details updated.</P></DESCRIPTION></WHATS_NEW_ENTRY><WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-09-24 12:31:30 +0200" MODIFIED_BY="Jessica Thomas"><DATE DAY="4" MONTH="7" YEAR="2010"/><DESCRIPTION><P>Contact details updated.</P></DESCRIPTION></WHATS_NEW_ENTRY><WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-07-04 14:23:28 +0200" MODIFIED_BY="Caroline Struthers"><DATE DAY="13" MONTH="5" YEAR="2009"/><DESCRIPTION><P>Contact details updated.</P></DESCRIPTION></WHATS_NEW_ENTRY><WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-05-13 13:30:57 +0200" MODIFIED_BY="Jessica Thomas">
<DATE DAY="28" MONTH="5" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-05-28 13:47:53 +0100" MODIFIED_BY="Sheena Derry">
<DATE DAY="15" MONTH="1" YEAR="2008"/>
<DESCRIPTION>
<P>Review updated - studies sought but none found</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2008-06-05 17:04:34 +0100" MODIFIED_BY="Jessica R Thomas">
<DATE DAY="15" MONTH="1" YEAR="2008"/>
<DESCRIPTION>
<P>Further studies satisfying our inclusion criteria were sought in MEDLINE (via Ovid), EMBASE (via Ovid) and Cochrane CENTRAL to December 2007. No further studies were identified, so the conclusions of the review are unchanged.<BR/>
<BR/>
</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="30" MONTH="12" YEAR="1999"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Pain Research Funds, Oxford</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>Biotechnology and Biological Sciences Research Council</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>SmithKline Beecham Consumer Healthcare</NAME>
<COUNTRY CODE="NONE">Not specified</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>European Union Biomed2 (#BMH4-CT95-0172)</NAME>
<COUNTRY CODE="NONE">Not specified</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>NHS R&amp;D Health Technology Evaluation Programmes</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>NHS Cochrane Collaboration Programme Grant Scheme</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-06-05 17:06:32 +0100" MODIFIED_BY="Jessica R Thomas">
<SUMMARY MODIFIED="2008-05-28 13:57:24 +0100" MODIFIED_BY="Sheena Derry">
<TITLE MODIFIED="2008-05-28 13:57:24 +0100" MODIFIED_BY="Sheena Derry">Dihydrocodeine in a single dose in the treatment of acute postoperative pain</TITLE>
<SUMMARY_BODY>
<P>This review assessed the efficacy of single-dose dihydrocodeine in adults with moderate/severe postoperative pain using information from randomised placebo controlled trials. There was a lack of data that could be included in the analyses; all assessed the oral form of the drug and none assessed dihydrocodeine 60 mg. The results were not robust. The implication was that single-dose oral dihydrocodeine 30 mg was more effective than placebo, but was inferior to ibuprofen 400 mg. Dizziness, drowsiness and confusion were commonly reported.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2008-06-05 17:06:25 +0100" MODIFIED_BY="Jessica R Thomas">
<ABS_BACKGROUND>
<P>This is an updated version of the original Cochrane review published in Issue 2, 2000. Dihydrocodeine is a synthetic opioid analgesic developed in the early 1900s. Its structure and pharmacokinetics are similar to that of codeine and it is used for the treatment of postoperative pain or as an antitussive. It is becoming increasingly important to assess the relative efficacy and harm caused by different treatments. Relative efficacy can be determined when an analgesic is compared with control under similar clinical circumstances.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To quantitatively assess the analgesic efficacy and adverse effects of single-dose dihydrocodeine compared with placebo in randomised trials in moderate to severe postoperative pain.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>Published reports were identified from electronic databases (MEDLINE, EMBASE, CENTRAL, the Oxford Pain Relief Database in December 2007, the original search was conducted in October 1999). Additional studies were identified from the reference lists of retrieved reports.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Inclusion criteria: full journal publication, clinical trial, random allocation of participants to treatment groups, double blind design, adult participants, baseline pain of moderate to severe intensity, postoperative administration of study drugs, treatment arms which included dihydrocodeine and placebo and either oral or injected (intramuscular or intravenous) administration of study drugs.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2008-06-05 17:06:25 +0100" MODIFIED_BY="Jessica R Thomas">
<P>Data collection and analysis: summed pain intensity and pain relief data over four to six hours were extracted and converted into dichotomous information to yield the number of participants obtaining at least 50% pain relief. This was used to calculate relative benefit and number-needed-to-treat-to-benefit (NNT) for one participant to obtain at least 50% pain relief. Single-dose adverse effect data were collected and used to calculate relative risk and number-needed-to-treat-to-harm (NNH).</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2008-06-05 17:05:22 +0100" MODIFIED_BY="Jessica R Thomas">
<P>Fifty-two reports were identified in the original review as possible randomised trials which assessed dihydrocodeine in postoperative pain. Four reports met the inclusion criteria; all assessed oral dihydrocodeine. Three reports (194 participants) compared dihydrocodeine with placebo and one (120 participants) compared dihydrocodeine (30 mg or 60 mg) with ibuprofen 400 mg. For a single dose of dihydrocodeine 30 mg in moderate to severe postoperative pain the NNT for at least 50% pain relief was 8.1 (95% confidence interval 4.1 to 540) when compared with placebo over a period of four to six hours. Pooled data showed significantly more participants to have reported adverse effects with dihydrocodeine 30 mg than with placebo. When compared to ibuprofen 400 mg both dihydrocodeine 30 mg and 60 mg were significantly inferior. No additional studies were found for this update.<BR/>
</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>A single 30 mg dose of dihydrocodeine is not sufficient to provide adequate pain relief in postoperative pain. Statistical superiority of ibuprofen 400 mg over dihydrocodeine (30 mg or 60 mg) was shown. Since the last version of this review no new relevant studies have been identified.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-06-05 17:06:32 +0100" MODIFIED_BY="Jessica R Thomas">
<BACKGROUND MODIFIED="2008-06-05 17:05:30 +0100" MODIFIED_BY="Jessica R Thomas">
<P>This is an update of a previously published review in the Cochrane Database of Systematic Reviews (Issue 2, 2000) on 'Single dose dihydrocodeine for the treatment of acute postoperative pain'.</P>
<P>Opioids are used extensively in the management of pain and are believed capable of relieving severe pain more effectively than non-steroidal anti-inflammatory drugs (NSAIDs) (<LINK REF="REF-Alexander-1987" TYPE="REFERENCE">Alexander 1987</LINK>). The aim of this systematic review was to assess the efficacy and safety of a single dose of dihydrocodeine in the management of postoperative pain of moderate to severe intensity.</P>
<P>Dihydrocodeine is a synthetic opioid analgesic developed in the early 1900s. Its structure and pharmacokinetics are similar to that of codeine (<LINK REF="REF-Rowell-1983" TYPE="REFERENCE">Rowell 1983</LINK>) and it is used for the treatment of postoperative pain or as an antitussive. In England, 2.2 million prescriptions were written for dihydrocodeine tablets in 2006, and 4.2 million prescriptions for dihydrocodeine in combination with paracetamol (<LINK REF="REF-PACT-2006" TYPE="REFERENCE">PACT 2006</LINK>). This is only about one-fifth of the level of use a decade earlier. The amount of dihydrocodeine used for the treatment of postoperative pain is not known, but it is not now commonly used to treat acute pain.</P>
<P>It is becoming increasingly important to assess the relative efficacy and harm caused by different treatments. Relative efficacy can be determined when an analgesic is compared with control under similar clinical circumstances. Mean pain outcome values from categorical pain intensity and pain relief scales (percent of maximum possible pain intensity or pain relief; %maxSPID and %maxTOTPAR) can be converted into dichotomous information (number of participants with at least 50% pain relief) (<LINK REF="REF-Moore-1996" TYPE="REFERENCE">Moore 1996</LINK>; <LINK REF="REF-Moore-1997a" TYPE="REFERENCE">Moore 1997a</LINK>; <LINK REF="REF-Moore-1997b" TYPE="REFERENCE">Moore 1997b</LINK>). This can then be used to derive the number-needed-to-treat-to-benefit (NNT) for at least 50% pain relief. Comparison of the NNTs against placebo for different analgesics allows a rank order of relative efficacy to be established.</P>
</BACKGROUND>
<OBJECTIVES>
<P>To quantitatively evaluate the analgesic efficacy and adverse effects of dihydrocodeine in moderate to severe postoperative pain. To compare its efficacy and safety to that of other analgesics assessed in the same way.</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-06-05 17:05:42 +0100" MODIFIED_BY="Jessica R Thomas">
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P>Studies were included if they were full journal publications of single-dose, double blind, randomised controlled (placebo or active) trials (RCTs) of dihydrocodeine over four to six hours in postoperative pain. Multiple dose studies were included if they provided single-dose data. Study drugs needed to have been administered (by injection or orally) postoperatively to adult participants with moderate or severe pain at baseline. </P>
<P>Studies were excluded if they did not state clearly that study medication had been randomly allocated or the method of randomisation was considered inappropriate (e.g. date of birth), or they examined other pain conditions (postfracture, postpartum uterine cramps, chronic pain, muscle strain, post-trauma pain).</P>
<P>Abstracts, review articles, case reports, clinical observations, and unpublished data were not sought. Neither pharmaceutical companies nor authors were contacted for unpublished reports.</P>
<P>Full details of the individual studies are provided in the 'Characteristics of included studies' and 'Characteristics of excluded studies' sections.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Adult participants with established postoperative pain of moderate to severe intensity.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Reports were included if they assessed participants who had been randomised to either dihydrocodeine (oral or injected) or placebo.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P>Pain outcomes used were TOTPAR, SPID, VAS TOTPAR or VAS SPID over four to six hours or sufficient data provided to allow their calculation. Pain measures allowed for the calculation of TOTPAR were a standard five point pain relief scale (none, slight, moderate, good, complete) and for SPID a standard four point pain intensity scale (none, mild, moderate, severe).</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-05-28 13:59:00 +0100" MODIFIED_BY="Sheena Derry">
<P>The following electronic databases were searched:<BR/>
</P>
<UL>
<LI>Cochrane CENTRAL (Issue 3, 1999 for the original review and Issue 4, 2007 for the update);</LI>
<LI>MEDLINE and Pre-MEDLINE from 1966 to October 1999 for the original review, and MEDLINE from January 1999 to December 2007 for the update;</LI>
<LI>EMBASE from 1989 to October 1999 for the original review and January 1999 to December 2007 for the update;</LI>
<LI>the Oxford Pain Relief database (handsearch records for the years 1954 to 1995 (<LINK REF="REF-Jadad-1996a" TYPE="REFERENCE">Jadad 1996a</LINK>).</LI>
</UL>
<P>The MEDLINE search strategy can be seen in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> and was adapted for the other databases searched.<BR/>
</P>
<P>Reference lists of retrieved reports were also manually searched.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-06-05 17:05:42 +0100" MODIFIED_BY="Jessica R Thomas">
<P>From each study we extracted:<BR/>(i) the number of participants treated,<BR/>(ii) mean TOTPAR, SPID, VAS TOTPAR or VAS SPID,<BR/>(iii) study duration,<BR/>(iv) the dose of dihydrocodeine,<BR/>(v) the dose of active comparator (if relevant),<BR/>(vi) information on adverse effects, and<BR/>(vii) information on remedication.</P>
<P>Mean TOTPAR, SPID, VAS TOTPAR and VAS SPID values were converted to %maxTOTPAR or %maxSPID by division into the calculated maximum value (<LINK REF="REF-Moore-1996" TYPE="REFERENCE">Moore 1996</LINK>). Verified equations were used to estimate the proportion of participants achieving at least 50% maxTOTPAR (<LINK REF="REF-Moore-1997a" TYPE="REFERENCE">Moore 1997a</LINK>; <LINK REF="REF-Moore-1997b" TYPE="REFERENCE">Moore 1997b</LINK>). This was then converted in to the number of participants achieving at least 50% maxTOTPAR by multiplying the figure by the total number of participants in the treatment group. The number of participants with at least 50% maxTOTPAR was then used to calculate estimates of relative benefit and NNT.</P>
<P>Relative benefit/risk estimates with 95% confidence intervals (CI) were calculated using the fixed-effect model (<LINK REF="REF-Morris-1995" TYPE="REFERENCE">Morris 1995</LINK>). Homogeneity was assumed when P &gt; 0.1 and was tested for using a chi-squared test. A statistically significant benefit of active treatment over placebo was assumed when the lower limit of the 95% CI of the relative benefit was &gt;1. A statistically significant benefit of placebo over active treatment was assumed when the upper limit of the 95% CI of the relative benefit was &lt;1. Number-needed-to-treat-to-harm (NNH) and NNT with 95% CIs were calculated (<LINK REF="REF-Cook-1995" TYPE="REFERENCE">Cook 1995</LINK>). The CI includes no benefit of one treatment over the other when the upper limit is represented as infinity. Calculations were performed with the help of Excel 5.0 on a Macintosh Performa 6320.</P>
<P>There was no attempt at anonymisation of the studies prior to assessment. Two review authors (JE, HM) independently carried out data abstraction and quality assessments. A consensus meeting with all review authors was held to agree on the data abstracted, the quality scores, the data to be used in the analyses, and the studies for inclusion in the review.</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-06-05 17:06:29 +0100" MODIFIED_BY="Jessica R Thomas">
<STUDY_DESCRIPTION>
<P>Fifty-two published reports of dihydrocodeine in postoperative pain (359 participants in total) were identified; one could not be obtained from the British Library (<LINK REF="STD-Hummel-1995" TYPE="STUDY">Hummel 1995</LINK>). Of the retrieved studies, 18 studies were not randomised or were abstracts and were excluded. Thirty-two studies were randomised. Of the randomised studies eight were not double blind (two were single blind), five did not specify baseline pain of moderate to severe intensity, five had no extractable pain outcome data, six did not assess the analgesic properties of dihydrocodeine, three included other pain conditions (e.g. chronic/cold-induced/trauma pain) and two did not use a placebo group. These studies were excluded (see 'Characteristics of excluded studies' table). </P>
<P>Four studies met the inclusion criteria from the original searches. No further studies were identified in the updated searches.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P>Each study was scored for quality using a three-item scale (see below) (<LINK REF="REF-Jadad-1996b" TYPE="REFERENCE">Jadad 1996b</LINK>); a consensus score was agreed for each study. The quality scores for individual studies are reported in the 'Characteristics of included studies' table. These scores were not used to weight the results in any way.</P>
<P>The three item scale is as follows: <BR/> Is the study randomised? If yes then one point <BR/> Is the randomisation procedure reported and is it appropriate? If yes then add one point, if not deduct one <BR/> Is the study double blind? If yes then one point <BR/> Is the double blind method reported and is it appropriate? If yes then add one point, if not deduct one <BR/> Are withdrawals and dropouts described? If yes add one point </P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-06-05 17:06:29 +0100" MODIFIED_BY="Jessica R Thomas">
<P>Four studies<I> </I>(359 participants)<I> </I>met the inclusion criteria: three were placebo-controlled and one used ibuprofen 400 mg as an active control. All four studies examined the effects of oral dihydrocodeine. Three of the studies (<LINK REF="STD-Frame-1989" TYPE="STUDY">Frame 1989</LINK>; <LINK REF="STD-Galasko-1989" TYPE="STUDY">Galasko 1989</LINK>; <LINK REF="STD-McQuay-1985" TYPE="STUDY">McQuay 1985</LINK>) compared dihydrocodeine 30 mg with placebo, and one (<LINK REF="STD-McQuay-1993" TYPE="STUDY">McQuay 1993</LINK>) compared dihydrocodeine (30 mg or 60 mg) with ibuprofen 400 mg. No additional studies were identified in the updated searches.<BR/>
<B>
<BR/>Oral dihydrocodeine versus placebo</B>
<BR/>No studies comparing dihydrocodeine 60 mg with placebo met the inclusion criteria. Three studies compared dihydrocodeine tartrate 30 mg (97 participants) with placebo (97 participants). One study investigated dental pain (<LINK REF="STD-Frame-1989" TYPE="STUDY">Frame 1989</LINK>), one orthopaedic pain (<LINK REF="STD-Galasko-1989" TYPE="STUDY">Galasko 1989</LINK>), and one pain following minor day-case surgery (<LINK REF="STD-McQuay-1985" TYPE="STUDY">McQuay 1985</LINK>).</P>
<P>The proportion of participants experiencing at least 50% pain relief with dihydrocodeine varied between 14% and 50% (mean 32%). The proportion of participants experiencing at least 50% pain relief with placebo varied between 5% and 50% (mean 20%). Dihydrocodeine 30 mg was significantly different from placebo, relative benefit 1.6 (1.01 to 2.5). For a single dose of dihydrocodeine 30 mg compared with placebo the NNT was 8.1 (4.1 to 540) for at least 50% pain relief over four to six hours in postoperative pain of moderate to severe intensity.</P>
<P>
<B>
<I>Adverse effects</I>
</B>
<BR/>The most frequently reported adverse effects were nausea, vomiting, headache, and central nervous system effects (dizziness/drowsiness/confusion). All were mild, transient in nature and no participants withdrew as a result.</P>
<P>
<I>Participants reporting any adverse effect</I>
<BR/>Information on the number of participants reporting any adverse effect was pooled. The proportion of participants who reported adverse effects was 13/67 with dihydrocodeine 30 mg and 4/69 with placebo. The relative risk was 3.4 (1.2 to 9.8) and the NNH was 7.4 (4.1 to 38).</P>
<P>
<I>Particular adverse effects</I>
<BR/>There was no significant difference in the reported incidence of particular (e.g. drowsiness) adverse effects with dihydrocodeine 30 mg than with placebo.<BR/>
<B>
<BR/>Oral dihydrocodeine versus ibuprofen</B>
<BR/>One study (<LINK REF="STD-McQuay-1993" TYPE="STUDY">McQuay 1993</LINK>) compared the efficacy and safety of either dihydrocodeine tartrate 30 mg (40 participants) or 60 mg (40 participants) with ibuprofen 400 mg (40 participants) in dental pain.</P>
<P>The proportion of participants experiencing at least 50% pain relief with dihydrocodeine 30 mg was 8%, with dihydrocodeine 60 mg it was 15%, and with ibuprofen 400 mg (active control) it was 45%. A statistical superiority of ibuprofen 400 mg over dihydrocodeine 30 mg and dihydrocodeine 60 mg was shown, relative benefit 0.2 (0.05 to 0.5) and 0.3 (0.2 to 0.8) respectively.</P>
<P>Ibuprofen 400 mg was significantly more effective than dihydrocodeine 30 mg or dihydrocodeine 60 mg. The NNT for a single dose of ibuprofen 400 mg compared to dihydrocodeine 30 mg was 2.7 (1.8 to 5.0) for at least 50% pain relief over a period of four to six hours in postoperative pain of moderate to severe intensity. For a single dose of ibuprofen 400 mg compared to dihydrocodeine 60 mg the NNT was 3.3 (2.0 to 9.1) for at least 50% pain relief over a period of four to six hours.</P>
<P>
<B>
<I>Adverse effects</I>
</B>
<BR/>No single dose adverse effect data were presented (<LINK REF="STD-McQuay-1993" TYPE="STUDY">McQuay 1993</LINK>).</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-06-05 17:06:32 +0100" MODIFIED_BY="Jessica R Thomas">
<P>We found no studies which investigated injected dihydrocodeine in the evaluation of postoperative pain with standard analgesic measurement methods.</P>
<P>For a single dose of oral dihydrocodeine tartrate 30 mg compared with placebo the NNT was 8.1 (4.1 to 540) for at least 50% pain relief over four to six hours in postoperative pain of moderate to severe intensity. This means that one in every eight participants with moderate to severe postoperative pain would experience at least 50% pain relief with dihydrocodeine 30 mg who would not have done with placebo.</P>
<P>A rank order of single dose analgesic efficacy in postoperative pain of moderate to severe intensity has been established by comparing orally administered analgesics from methodologically similar studies. This rank order has been published previously, both in its entirety (<LINK REF="REF-McQuay-1998" TYPE="REFERENCE">McQuay 1998</LINK>), for third molar extraction studies only (<LINK REF="REF-Barden-2004" TYPE="REFERENCE">Barden 2004</LINK>), and as individual reports (<LINK REF="REF-Collins-1998a" TYPE="REFERENCE">Collins 1998a</LINK>; <LINK REF="REF-Collins-1998b" TYPE="REFERENCE">Collins 1998b</LINK>; <LINK REF="REF-Moore-1997c" TYPE="REFERENCE">Moore 1997c</LINK>; <LINK REF="REF-Moore-1997d" TYPE="REFERENCE">Moore 1997d</LINK>). It is also available on the World Wide Web (http://www.jr2.ox.ac.uk/bandolier/painres/painpag/Acutrev/Analgesics/Leagtab.html) or is available from the authors. The rank order shows the results of a number of meta-analyses which compare analgesic with placebo in acute postoperative pain. The point estimates of the NNTs of many of these analgesics are lower (better) than that of dihydrocodeine 30 mg (for example: paracetamol, paracetamol plus codeine and dextropropoxyphene plus paracetamol) although the CIs overlap. The CIs of the NNTs for ibuprofen 400 mg, tramadol 150 mg and ibuprofen 200 mg do not overlap with those of dihydrocodeine 30 mg indicating greater analgesic efficacy.</P>
<P>This rank order of relative efficacy against placebo is supported by a head-to-head comparison with ibuprofen (<LINK REF="STD-McQuay-1993" TYPE="STUDY">McQuay 1993</LINK>). The analgesic efficacy of a single dose of oral ibuprofen 400 mg was significantly better than dihydrocodeine (30 mg or 60 mg). The NNT was 2.7 (1.8 to 5.0) for at least 50% pain relief over a period of four to six hours in postoperative pain of moderate to severe intensity. This means that for every three participants with moderate to severe postoperative pain treated with ibuprofen 400 mg one will experience at least 50% pain relief who would not have done if given dihydrocodeine 30 mg. Similarly, for a single dose of ibuprofen 400 mg compared with dihydrocodeine 60 mg the NNT was 3.3 (2.1 to 9.0) over a period of four to six hours.</P>
<P>Nausea, vomiting, headache, dizziness, drowsiness and confusion were the most commonly reported adverse effects with a single dose of oral dihydrocodeine 30 mg compared with placebo. Significantly more participants reported at least one adverse effect with dihydrocodeine 30 mg than with placebo; the NNH was 7.4 (4.1 to 38). This means that for every seven participants treated with dihydrocodeine 30 mg one would experience an adverse effect who would not have done with placebo.</P>
<P>Our results suggest dihydrocodeine to be less effective than other analgesics when administered as a single oral dose. Few of the retrieved reports investigating oral dihydrocodeine met the criteria for inclusion in this quantitative systematic review. This resulted in little participant data being available for analysis, particularly for dihydrocodeine 60 mg which is often the preferred dose. Administering dihydrocodeine in multiple doses may improve its analgesic efficacy, but may also increase the incidence of adverse effects (<LINK REF="STD-McQuay-1993" TYPE="STUDY">McQuay 1993</LINK>).</P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>The update of this review has not identified any further information to provide evidence for or against the use of single dose dihydrocodeine for acute postoperative pain. Based on the limited amount of information in the available studies, a 30 mg dose of dihydrocodeine is not sufficient to provide good pain relief and higher doses are required. When compared with ibuprofen 400 mg, fewer participants benefited with dihydrocodeine (30 mg and 60 mg). </P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>The annual prescriptions for dihydrocodeine in the UK alone indicate it to be a commonly used drug. To date, there is not enough high quality data available, especially for dihydrocodeine 60 mg, on which to make policy decisions. </P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>We would like to thank Claire Abbott at the Cairns Library for helping to obtain reports.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>SD has no interests to declare. RAM has been a consultant for MSD. RAM and HJM have consulted for various pharmaceutical companies. RAM, HJM and JR have received lecture fees from pharmaceutical companies related to analgesics and other healthcare interventions. All authors have received research support from charities, government and industry sources at various times: no such support was received for this work.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>Original review<BR/>JR: was involved with searching, data extraction, analysis and writing. <BR/>AM and HJM were involved with analysis and writing.</P>
<P>Update 2008 <BR/>SD and AM carried out the searching and writing.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES>
<P>The review authors consider that additional relevant studies are unlikely to be conducted in the future, and that further updates of this review are unnecessary.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES>
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Frame-1989" NAME="Frame 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frame JW, Evans RH, Flaum GR, Langford R, Rout PGJ</AU>
<TI>A comparison of ibuprofen and dihydrocodeine in relieving pain following wisdom teeth removal</TI>
<SO>British Dental Journal</SO>
<YR>1989</YR>
<VL>166</VL>
<PG>121-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Galasko-1989" NAME="Galasko 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Galasko CSB, Russel S, Lloyd J</AU>
<TI>Double-blind investigation of the efficacy of multiple doses of ketorolac tromethamine compared with dihydrocodeine and placebo</TI>
<SO>Current Therapeutic Research</SO>
<YR>1989</YR>
<VL>45</VL>
<PG>844-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McQuay-1985" NAME="McQuay 1985" YEAR="1985">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McQuay HJ, Bullingham RES, Moore RA, et al</AU>
<TI>Zomepirac, dihydrocodeine and placebo compared in postoperative pain after day-case surgery. The relationship between the effects of single and multiple doses</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1985</YR>
<VL>57</VL>
<PG>412-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McQuay-1993" NAME="McQuay 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McQuay HJ, Carroll D, Guest PG, Robson S, Wiffen PJ, Juniper RP</AU>
<TI>A multiple dose comparison of ibuprofen and dihydrocodeine after third molar surgery</TI>
<SO>The British Journal of Oral and Maxillofacial Surgery</SO>
<YR>1993</YR>
<VL>31</VL>
<PG>95-100</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Aitken-1990" NAME="Aitken 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aitken HA, Clark EC, McArdle CS, Dimitri W, Kenny GN</AU>
<TI>Evaluation of two formulations of dihydrocodeine using patient controlled analgesia</TI>
<SO>Anaesthesia</SO>
<YR>1990</YR>
<VL>45</VL>
<NO>7</NO>
<PG>535-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Beecher-1957" NAME="Beecher 1957" YEAR="1957">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Beecher HK, Gravenstein JS, Pederson DP, Smith GM</AU>
<TI>Analgesic efects and side effect liability of dihydrocodeine and morphine in man</TI>
<SO>Federation Proceedings</SO>
<YR>1957</YR>
<VL>16</VL>
<PG>281</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brittain-1959" NAME="Brittain 1959" YEAR="1959">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brittain GJC</AU>
<TI>Dihydrohydroxycodeinone pectinate</TI>
<SO>The Lancet</SO>
<YR>1959</YR>
<VL>(no volume)</VL>
<PG>544-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brown-1993" NAME="Brown 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brown P, Mehlisch DR, Kiersch T, Allan G, Sims I</AU>
<TI>A single dose study evaluating the analgesic efficacy of hydocodone / acetaminophen, oxycodone / acetaminophen and placebo following oral surgery</TI>
<SO>American Society for Clinical Pharmacology and Therapeutics</SO>
<YR>1993</YR>
<VL>53</VL>
<PG>172</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cahill-1987" NAME="Cahill 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cahill DJ, McFaul PB</AU>
<TI>Local anaesthesia with bupivacaine following laparoscopy: a double blind controlled trial</TI>
<SO>Journal of Obstetrics and Gynecology</SO>
<YR>1987</YR>
<VL>7</VL>
<NO>4</NO>
<PG>277-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carapeti-1998" NAME="Carapeti 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carapeti EA, Kamm MA, McDonald PJ, Phillips RK</AU>
<TI>Double-blind randomised controlled trial of effect of metronidazole on pain after day-case haemorrhoidectomy</TI>
<SO>Lancet</SO>
<YR>1998</YR>
<VL>351</VL>
<PG>169-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Daniel-1971" NAME="Daniel 1971" YEAR="1971">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Daniel JR</AU>
<TI>Two comparisons of the analgesic activity of orally administered pentazocine, dihydrocodeine and placebo</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1971</YR>
<VL>42</VL>
<PG>392-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eddy-1934" NAME="Eddy 1934" YEAR="1934">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eddy NB</AU>
<TI>Studies of morphine, codeine and their derivatives. IV. Hydrogenated codeine isomers</TI>
<SO>The Journal of Pharmacology and Experimental Therapeutics</SO>
<YR>1934</YR>
<VL>51</VL>
<PG>35-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fassoulaki-1995" NAME="Fassoulaki 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fassoulaki A, Sarantopoulos C, Zotou M, Papoulia D</AU>
<TI>Preemptive opioid analgesia does not influence pain after abdominal hysterectomy</TI>
<SO>Canadian Journal of Anaesthesia</SO>
<YR>1995</YR>
<VL>42</VL>
<NO>2</NO>
<PG>109-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fenton_x002d_Lee-1994" NAME="Fenton-Lee 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>FentonLee D, Riach E, Cooke T</AU>
<TI>The use of a local anaesthetic wound perfusion device versus oral analgesia. A comparison in day case inguinal herniorrhaphy</TI>
<SO>British Journal of Intensive Care</SO>
<YR>1994</YR>
<VL>4</VL>
<NO>5</NO>
<PG>152, 154-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fricke-1993" NAME="Fricke 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fricke J, Halladay SC</AU>
<TI>Comparison of keterolac, hydrocodone plus acetaminophen and placebo for the relief of dental surgery pain</TI>
<SO>Clinical Pharmacology and Therapeutics</SO>
<YR>1993</YR>
<VL>53</VL>
<PG>222</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Galasko-1988" NAME="Galasko 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Galasko CS, Courtney P, Jayne M, Coxhead PF, Russell S</AU>
<TI>Comparison of the efficacy of naproxen sodium and dihydrocodeine tartrate in the treatment of post operative pain</TI>
<SO>Current Medical Research and Opinion</SO>
<YR>1988</YR>
<VL>10</VL>
<NO>10</NO>
<PG>656-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grace-1994" NAME="Grace 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grace D, Milligan KR, Morrow BJ, Fee JPH</AU>
<TI>Co-administration of pethidine and clonidine: A spinal anaesthetic technique for total hip replacement</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1994</YR>
<VL>73</VL>
<NO>5</NO>
<PG>628-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grainger-1977" NAME="Grainger 1977" YEAR="1977">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grainger DJ, Gawley TH, Dundee JW</AU>
<TI>Anidoxime: a clinical trial of an oral analgesic agent</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1977</YR>
<VL>49</VL>
<NO>3</NO>
<PG>257-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gravenstein-1956" NAME="Gravenstein 1956" YEAR="1956">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gravenstein JS, Smith GM, Sphire RD, Isaacs JP, Beecher HK</AU>
<TI>Dihydrocodeine. Further development in measurement of analgesic power and appraisal of psychologic side efects of analgesic agents</TI>
<SO>New England Journal of Medicine</SO>
<YR>1956</YR>
<VL>254</VL>
<PG>877</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Habib-1990" NAME="Habib 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Habib S, Matthews RW, Scully C, Levers BG, Shepherd JP</AU>
<TI>A study of the comparative efficacy of four common analgesics in the control of postsurgical dental pain</TI>
<SO>Oral surgery, Oral Medicine, and Oral Pathology</SO>
<YR>1990</YR>
<VL>70</VL>
<NO>5</NO>
<PG>559-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Heath-1989" NAME="Heath 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heath PJ, Ogg TW</AU>
<TI>Prophylactic analgesia for daycase termination of pregnancy. A double blind study with controlled release dihydrocodeine</TI>
<SO>Anaesthesia</SO>
<YR>1989</YR>
<VL>44</VL>
<NO>12</NO>
<PG>991-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Henderson-1999" NAME="Henderson 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Henderson DJ, Withington BS, Wilson JA, Morrison LM</AU>
<TI>Perioperative dextromethorphan reduces postoperative pain after hysterectomy</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1999</YR>
<VL>89</VL>
<PG>399-402</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Howard-1953" NAME="Howard 1953" YEAR="1953">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Howard BK et al</AU>
<TI>[No title]</TI>
<SO>Journal of Obstetrics and Gynecology</SO>
<YR>1953</YR>
<VL>1</VL>
<PG>371</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hummel-1995" NAME="Hummel 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hummel T, Kraetsch HG, Loetsch J, Hepper M, Liefhold J, Kobal G</AU>
<TI>Analgesic Effects of Dihydrocodeine and Tramadol when Administered Either in the Morning or Evening</TI>
<SO>Chronobiology International</SO>
<YR>1995</YR>
<VL>12</VL>
<PG>62-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jorgensen-1985" NAME="Jorgensen 1985" YEAR="1985">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jorgensen BC, Schmidt JF, Risbo A, Pedersen J, Kolby P</AU>
<TI>Regular interval preventive pain relief compared with in demand treatment after hysterectomy</TI>
<SO>Pain</SO>
<YR>1985</YR>
<VL>21</VL>
<PG>137-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kay-1988" NAME="Kay 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kay B, Lindsay RG, Mason CJ, Healy TEJ</AU>
<TI>Oral nalbuphine for the treatment of pain after dental extractions</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1988</YR>
<VL>61</VL>
<NO>3</NO>
<PG>313-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Keats-1950" NAME="Keats 1950" YEAR="1950">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Keats AS, Beecher HK, Mosteller FC</AU>
<TI>Measurement of pathological pain in distinction to experimental pain</TI>
<SO>[Journal title unknown]</SO>
<YR>1950</YR>
<VL>3</VL>
<PG>35-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Keats-1957a" NAME="Keats 1957a" YEAR="1957">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Keats AS, Telford J, Kurosu Y</AU>
<TI>Studies of two new potent analgesics: Anileridine and dihydrocodeine</TI>
<SO>Anesthesiology</SO>
<YR>1957</YR>
<VL>18</VL>
<PG>168</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Keats-1957b" NAME="Keats 1957b" YEAR="1957">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Keats AS</AU>
<TI>Studies of analgesic drugs: dihydrocodeine</TI>
<SO>The Journal of Pharmacology and Experimental Therapeutics</SO>
<YR>1957</YR>
<VL>120</VL>
<PG>354-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kerrick-1993" NAME="Kerrick 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kerrick JM, Fine PG, Lipman AG, Love G</AU>
<TI>Low-dose amitriptyline as an adjunct to opioids for postoperative orthopedic pain: A placebo-controlled trial</TI>
<SO>Pain</SO>
<YR>1993</YR>
<VL>52</VL>
<NO>3</NO>
<PG>325-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lipton-1975" NAME="Lipton 1975" YEAR="1975">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lipton S, Conway M, Akbar FA</AU>
<TI>An analgesic comparison of floctafenine (Idarac) and dihydrocodeine in post-operative pain</TI>
<SO>The Journal of International Medical Research</SO>
<YR>1975</YR>
<VL>3</VL>
<PG>172-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lomas-1976" NAME="Lomas 1976" YEAR="1976">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lomas DM, Gay J, Midha RN, Postlethwaite DL</AU>
<TI>A double-blind comparative clinical trial of floctafenine and four other analgesics conducted in general practice</TI>
<SO>The Journal of International Medical Research</SO>
<YR>1976</YR>
<VL>4</VL>
<NO>3</NO>
<PG>179-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lund-1959" NAME="Lund 1959" YEAR="1959">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lund I, Lind B</AU>
<TI>A comparison of pethidine and dihydrocodeine for the relief of labour pain</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>1959</YR>
<VL>3</VL>
<PG>41-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Masson-1981" NAME="Masson 1981" YEAR="1981">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Masson AH</AU>
<TI>Sublingual buprenorphine versus oral dihydrocodeine in post operative pain</TI>
<SO>The Journal of International Medical Research</SO>
<YR>1981</YR>
<VL>9</VL>
<NO>6</NO>
<PG>506-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moore-1983" NAME="Moore 1983" YEAR="1983">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moore RA, Bullingham RE, Simpson S, O'Sullivan G, Evans PJ, McQuay HJ, Lloyd JW</AU>
<TI>Comparison of flupirtine maleate and dihydrocodeine in patients following surgery</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1983</YR>
<VL>55</VL>
<NO>5</NO>
<PG>429-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Morrison-1971" NAME="Morrison 1971" YEAR="1971">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Morrison JD, Loan WB, Dundee JW</AU>
<TI>Controlled comparison of the efficacy of fourteen preparations in the relief of postoperative pain</TI>
<SO>British Medical Journal</SO>
<YR>1971</YR>
<VL>3</VL>
<PG>287-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Myers-1958" NAME="Myers 1958" YEAR="1958">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Myers JD</AU>
<TI>A preliminary clinical evaluation of dihydrocodeine-bitartrate in normal parturition</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1958</YR>
<VL>75</VL>
<PG>1096-100</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Riethmuller-1987" NAME="Riethmuller 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Riethmuller Winzen H</AU>
<TI>Flupirtine in the treatment of post-operative pain</TI>
<SO>Postgraduate Medical Journal</SO>
<YR>1987</YR>
<VL>63</VL>
<NO>S3</NO>
<PG>61-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ruch-1957" NAME="Ruch 1957" YEAR="1957">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ruch WA</AU>
<TI>A preliminary report of dihydrocodeine-scopolamine in obstetrics</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1957</YR>
<VL>74</VL>
<PG>1125-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Seymour-1981" NAME="Seymour 1981" YEAR="1981">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Seymour RA, Rawlins MD</AU>
<TI>Paracetamol (acetaminophen), aspirin, dihydrocodeine tartrate and post-operative dental pain</TI>
<SO>Pain</SO>
<YR>1981</YR>
<VL>5</VL>
<PG>S248</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Seymour-1982" NAME="Seymour 1982" YEAR="1982">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Seymour RA, Rawlins MD, Rowell FJ</AU>
<TI>Dihydrocodeine-induced hyperalgesia in postoperative dental pain</TI>
<SO>Lancet</SO>
<YR>1982</YR>
<VL>1</VL>
<NO>8287</NO>
<PG>1425-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Seymour-1983a" NAME="Seymour 1983a" YEAR="1983">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Seymour RA</AU>
<TI>Analgesic efficacy and plasma concentration of three analgesics in pain after lower third molar removal</TI>
<SO>SAAD Digest</SO>
<YR>1983</YR>
<VL>5</VL>
<PG>172-88</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Seymour-1983b" NAME="Seymour 1983b" YEAR="1983">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Seymour RA et al</AU>
<TI>Postoperative dental pain and analgesic efficacy, part II. Analgesic usage and efficacy after dental surgery</TI>
<SO>The British Journal of Oral Surgery</SO>
<YR>1983</YR>
<VL>21</VL>
<PG>298-303</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sliom-1970" NAME="Sliom 1970" YEAR="1970">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sliom CM</AU>
<TI>Analgesia during labour: a comparison between dihydrocodeine and pethidine</TI>
<SO>South African Medical Journal</SO>
<YR>1970</YR>
<VL>44</VL>
<NO>11</NO>
<PG>317-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Squirrell-1998" NAME="Squirrell 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Squirrell DM, Majeed AW, Troy G, Peacock JE, Nicholl JP, Johnson AG</AU>
<TI>A randomized, prospective, blinded comparison of postoperative pain, metabolic response, and perceived health after laparoscopic and small incision cholecystectomy</TI>
<SO>Surgery</SO>
<YR>1998</YR>
<VL>123</VL>
<PG>485-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Traykova-1996" NAME="Traykova 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Traykova V et al</AU>
<TI>Dihydrocodeine-continus for postoperative pain relief in gynecology</TI>
<SO>Akusherstvo i Ginekologiia</SO>
<YR>1996</YR>
<VL>35</VL>
<PG>24-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Walker-1977" NAME="Walker 1977" YEAR="1977">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Walker JE, Kay LW</AU>
<TI>Postoperative jaw pain: floctafenine versus dihydrocodeine</TI>
<SO>International Journal of Oral Surgery</SO>
<YR>1977</YR>
<VL>6</VL>
<NO>5</NO>
<PG>256-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Walters-1984" NAME="Walters 1984" YEAR="1984">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Walters BNJ, Smith VA, De Swiet M</AU>
<TI>Comparative Trial of Suprofen and Dihydrocodeine in Post-Episiotomy Pain</TI>
<SO>Pain</SO>
<YR>1984</YR>
<VL>91</VL>
<PG>S236</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Walters-1985" NAME="Walters 1985" YEAR="1985">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Walters BN, Smith VA, De SwietM, Mustill TA</AU>
<TI>Pain relief after episiotomy a comparative study of suprofen and dihydrocodeine</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1985</YR>
<VL>92</VL>
<NO>11</NO>
<PG>1160-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Williams-1995" NAME="Williams 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Williams JE, Ainley TC, Shepherd JE</AU>
<TI>Economic impact of a patient-controlled oral analgesia system for post-operative pain</TI>
<SO>British Journal of Medical Economics</SO>
<YR>1995</YR>
<VL>9</VL>
<NO>1</NO>
<PG>41-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wotherspoon-1991" NAME="Wotherspoon 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wotherspoon HA, Kenny GNC, McArdle CS</AU>
<TI>Analgesic efficacy of controlled-release dihydrocodeine. A comparison of 60, 90 and 120 mg tablets in cold-induced pain</TI>
<SO>Anaesthesia</SO>
<YR>1991</YR>
<VL>46</VL>
<PG>915-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yadav-1984" NAME="Yadav 1984" YEAR="1984">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yadav S, McLatchie GR, Mackenzie I</AU>
<TI>Evaluation of proctofoam as a post-operative analgesic in patients undergoing haemorrhoidectomy</TI>
<SO>The British Journal of Clinical Practice</SO>
<YR>1984</YR>
<VL>38</VL>
<NO>11-12</NO>
<PG>414-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES>
<ADDITIONAL_REFERENCES>
<REFERENCE ID="REF-Alexander-1987" NAME="Alexander 1987" TYPE="BOOK_SECTION">
<AU>Alexander JI and Hill RG</AU>
<TI>Choices in the management of postoperative pain</TI>
<SO>Postoperative Pain</SO>
<YR>1987</YR>
<PG>130-1</PG>
<PB>Blackwell Scientific Publications</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Barden-2004" NAME="Barden 2004" TYPE="JOURNAL_ARTICLE">
<AU>Barden J, Edwards JE, McQuay HJ, Wiffen PJ, Moore RA</AU>
<TI>Relative efficacy of oral analgesics after third molar extraction</TI>
<SO>British Dental Journal</SO>
<YR>2004</YR>
<VL>197</VL>
<NO>7</NO>
<PG>407-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Collins-1998a" NAME="Collins 1998a" TYPE="JOURNAL_ARTICLE">
<AU>Collins SL, Edwards JE, Moore RA, McQuay HJ</AU>
<TI>Dextropropoxyphene in postoperative pain: A quantitative systematic review</TI>
<SO>European Journal of Clinical Pharmacology</SO>
<YR>1998</YR>
<VL>54</VL>
<PG>107-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Collins-1998b" NAME="Collins 1998b" TYPE="JOURNAL_ARTICLE">
<AU>Collins SL, Moore RA, Wiffen PJ, McQuay HJ</AU>
<TI>Oral ibuprofen and diclofenac in postoperative pain: a quantitative systematic review</TI>
<SO>European Journal of Pain</SO>
<YR>1998</YR>
<VL>2</VL>
<PG>285-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cook-1995" NAME="Cook 1995" TYPE="JOURNAL_ARTICLE">
<AU>Cook RJ, Sackett DL</AU>
<TI>The number needed to treat: a clinically useful measure of treatment effect</TI>
<SO>British Medical Journal</SO>
<YR>1995</YR>
<VL>310</VL>
<PG>452-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jadad-1996a" NAME="Jadad 1996a" TYPE="JOURNAL_ARTICLE">
<AU>Jadad AR, Carroll D, Moore A, McQuay HJ</AU>
<TI>Developing a database of published reports of randomised clinical trials in pain research</TI>
<SO>Pain</SO>
<YR>1996</YR>
<VL>66</VL>
<PG>239-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jadad-1996b" NAME="Jadad 1996b" TYPE="JOURNAL_ARTICLE">
<AU>Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ</AU>
<TI>Assessing the quality of reports of randomized clinical trials: is blinding necessary?</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1996</YR>
<VL>17</VL>
<PG>1-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McQuay-1998" NAME="McQuay 1998" TYPE="BOOK">
<AU>McQuay HJ, Moore RA</AU>
<SO>An Evidence-Based Resource for Pain Relief</SO>
<YR>1998</YR>
<PB>Oxford University Press</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moore-1996" NAME="Moore 1996" TYPE="JOURNAL_ARTICLE">
<AU>Moore RA, McQuay HJ, Gavaghan DJ</AU>
<TI>Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics</TI>
<SO>Pain</SO>
<YR>1996</YR>
<VL>66</VL>
<PG>229-37</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moore-1997a" NAME="Moore 1997a" TYPE="JOURNAL_ARTICLE">
<AU>Moore RA, McQuay HJ, Gavaghan DJ</AU>
<TI>Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: verification from independent data</TI>
<SO>Pain</SO>
<YR>1997</YR>
<VL>69</VL>
<PG>127-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moore-1997b" NAME="Moore 1997b" TYPE="JOURNAL_ARTICLE">
<AU>Moore RA, Moore O, McQuay HJ, Gavaghan DJ</AU>
<TI>Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: use of pain intensity and visual analogue scales</TI>
<SO>Pain</SO>
<YR>1997</YR>
<VL>69</VL>
<PG>311-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moore-1997c" NAME="Moore 1997c" TYPE="JOURNAL_ARTICLE">
<AU>Moore RA, Collins SA, McQuay HJ</AU>
<TI>Paracetamol with and without codeine: A quantitative systematic review</TI>
<SO>Pain</SO>
<YR>1997</YR>
<VL>70</VL>
<PG>193-201</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moore-1997d" NAME="Moore 1997d" TYPE="JOURNAL_ARTICLE">
<AU>Moore RA, McQuay HJ</AU>
<TI>Single-patient data meta-analysis of 3453 postoperative patients: oral tramadol versus placebo, codeine and combination analgesics</TI>
<SO>Pain</SO>
<YR>1997</YR>
<VL>69</VL>
<PG>287-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Morris-1995" NAME="Morris 1995" TYPE="BOOK_SECTION">
<AU>Morris JA, Gardner MJ</AU>
<TI>Calculating confidence intervals for relative risk, odds ratios and standardised ratios and rates</TI>
<SO>Statistics With Confidence - Confidence Intervals and Statistical Guidelines</SO>
<YR>1995</YR>
<PG>50-63</PG>
<ED>Gardner MJ , Altman DG</ED>
<PB>British Medical Journal</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-PACT-2006" NAME="PACT 2006" TYPE="OTHER">
<AU>Anonymous</AU>
<TI>Prescription Cost Analysis, England 2006</TI>
<SO>ISBN: 1-84636-053-6</SO>
<YR>2006</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rowell-1983" NAME="Rowell 1983" TYPE="JOURNAL_ARTICLE">
<AU>Rowell FJ, Seymour RA, Rawlins MD</AU>
<TI>Pharmacokinetics of intravenous and oral dihydrocodeine and its metabolites</TI>
<SO>European Journal of Clinical Pharmacology</SO>
<YR>1983</YR>
<VL>25</VL>
<PG>419-24</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Frame-1989">
<CHAR_METHODS>
<P>RCT, DB, single oral dose, parallel groups.</P>
<P>Assessed at t = 1/2, 1 hour and then hourly for 5 hrs.</P>
<P>Medication taken when pain of moderate to severe intensity<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Impacted third molar removal</P>
<P>n = 148</P>
<P>Age: Adults<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>DHC 30 mg, n = 49</P>
<P>Placebo, n = 50<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Measures: <BR/>PI (9 point scale ) nonstandard<BR/>PR (5 point scale) standard</P>
<P>Analgesic outcome:<BR/>DHC 30 mg was not significantly different to placebo.</P>
<P>5 hr TOTPAR:<BR/>DHC 30 mg: 4.2</P>
<P>Placebo: 2.6</P>
<P>
<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Remedication allowed at t &gt; 2 hrs.</P>
<P>If remedicated patients were withdrawn and their PR set to zero for all further time points.</P>
<P>Withdrawals:<BR/>18 withdrew:<BR/>9 insufficient pain, 7 did not return assessment forms, 1 did not complete assessment forms, 1 postoperative complications</P>
<P>Adverse effects:<BR/>No serious adverse effects were reported and no patients withdrew as a result. <BR/>DHC 30 mg: 1/49 with 1 AE</P>
<P>Placebo: 1/50 with 3 AE</P>
<P>Quality score: 3</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Galasko-1989">
<CHAR_METHODS>
<P>RCT, DB, multiple oral dose, parallel groups.</P>
<P>Assessed at t = 1/2, 1 hour and then hourly for 6 hrs.</P>
<P>Medication taken when pain of moderate to severe intensity<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Orthopaedic surgery</P>
<P>n = 89</P>
<P>Age: 18 - 80 years<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>DHC 30 mg, n = 30</P>
<P>Placebo, n = 28<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Measures: <BR/>PI (5 point scale ) nonstandard</P>
<P>PR (5 point scale) standard</P>
<P>VAS 100 mm (no pain - worst pain I have ever felt)</P>
<P>Analgesic outcomes:<BR/>DHC was not significantly different to placebo.</P>
<P>Mean TOTPAR at 6 hours:<BR/>DHC: 11.3</P>
<P>Placebo: 11.1</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Remedication:<BR/>Multiple dose study, 2nd dose given as required.</P>
<P>If remedicated patients were excluded from the analysis.</P>
<P>Withdrawals:<BR/>9 withdrew because of inadequate analgesia after the first dose.</P>
<P>DHC 30 mg, n = 3<BR/>Placebo, n = 6</P>
<P>Adverse effects:<BR/>No patients experienced adverse effects in the single dose analysis.</P>
<P>Quality score: 4</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-McQuay-1985">
<CHAR_METHODS>
<P>RCT, DB, multiple oral dose, parallel groups.</P>
<P>Assessed at t = 1/2, 1 hour and then hourly for 4 hrs.</P>
<P>Medication taken when pain of moderate to severe intensity</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Minor day-case surgery (general)</P>
<P>n = 54</P>
<P>Age: Adults<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>DHC 30 mg, n = 18</P>
<P>Placebo, n = 19</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Outcome measures:<BR/>PI (4 point scale) standard<BR/>PR (5 point scale) standard<BR/>VAS 100 mm</P>
<P>Analgesic outcomes:<BR/>4 hr SPID and TOTPAR presented.</P>
<P>TOTPAR:<BR/>DHC was significantly better than placebo (P&lt;0.05)</P>
<P>DHC30 mg: 6.5</P>
<P>Placebo: 3.2</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Remedication:<BR/>Allowed after 1 hr.</P>
<P>If remedicated patients initial PI and PR scores were used for all further time points.</P>
<P>Withdrawals and adverse effects:<BR/>Single dose analysis:</P>
<P>All adverse effects were mild and no patients withdrew as a result.</P>
<P>No significant difference was found between DHC and placebo .</P>
<P>DHC 30 mg: 6/18 with 6 AE</P>
<P>Placebo: 3/19 with 3 AE</P>
<P>Quality score: 4</P>
<P>
<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-McQuay-1993">
<CHAR_METHODS>
<P>RCT, DB, multiple oral dose, crossover design.</P>
<P>Self-assessed at t = 1/2. 1 hr and then hourly for 6 hrs.</P>
<P>Medication allowed when pain of moderate to severe intensity<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Lower third molar removal.</P>
<P>n = 68</P>
<P>Age = Adults<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>DHC 30 mg, n = 40</P>
<P>DHC 60 mg, n = 40</P>
<P>Placebo, n = 40<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Outcome measures:<BR/>PI (4 point scale ) standard</P>
<P>PR (5 point scale) standard</P>
<P>Global rating (5 point scale) standard</P>
<P>Analgesic outcomes:<BR/>TOTPAR at 6 hrs: </P>
<P>DHC 30 mg : 3.3</P>
<P>DHC 60 mg: 4.7</P>
<P>Ibuprofen 400 mg: 10.0</P>
<P>Ibuprofen was significantly better than dihydrocodeine 30 mg or 60 mg (P &lt; 0.01)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Remedication:<BR/>If remedicated at t&lt; 6 hrs the initial PI score and PR score of zero were used for all further time points.</P>
<P>Withdrawals:<BR/>3 patients withdrew.</P>
<P>Adverse effects:<BR/>Single dose adverse effects data was not presented.</P>
<P>Quality score: 4</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>Abbreviations: <BR/>DHC = dihydrocodeine; <BR/>R = randomised; <BR/>DB = double blind; <BR/>PI = pain intensity; <BR/>PR = pain relief; <BR/>AE = adverse effect.<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Aitken-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>No data to extract</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Beecher-1957">
<CHAR_REASON_FOR_EXCLUSION>
<P>Abstract</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Brittain-1959">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Brown-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Abstract</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cahill-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>No data to extract: no pain outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Carapeti-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Dihydrocodeine used as a rescue analgesic only</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Daniel-1971">
<CHAR_REASON_FOR_EXCLUSION>
<P>Included chronic pain/trauma and fracture</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Eddy-1934">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fassoulaki-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Did not assess analgesic properties of DHC. Assessed morphine consumption not pain outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fenton_x002d_Lee-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not double blind. No pain outcome data to extract</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fricke-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Abstract</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Galasko-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Single blind</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Grace-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Did not assess analgesic properties of DHC. No placebo control (used suprofen)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Grainger-1977">
<CHAR_REASON_FOR_EXCLUSION>
<P>Baseline pain not moderate or severe</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gravenstein-1956">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Habib-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Single blind</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Heath-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Baseline pain not moderate or severe</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Henderson-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Assessed dextromethorphan not DHC. Combination of dihydrocodeine with another drug</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Howard-1953">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hummel-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Could not be obtained: no UK location</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jorgensen-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not double blind</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kay-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>No data to extract</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Keats-1950">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised controlled trial. No placebo control (used floctafenine)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Keats-1957a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Abstract. No placebo control (used nalbuphine)<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Keats-1957b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not double blind. No control group<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kerrick-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Did not assess analgesic properties of DHC</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lipton-1975">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised. No placebo control (used MST + DF118)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lomas-1976">
<CHAR_REASON_FOR_EXCLUSION>
<P>Chronic pain</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lund-1959">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised. No placebo control (used buprenorphine)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Masson-1981">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not double blind. No placebo control (used seconal). Included children (i.e. &lt;16 yrs)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Moore-1983">
<CHAR_REASON_FOR_EXCLUSION>
<P>No data to extract: placebo data not presented</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Morrison-1971">
<CHAR_REASON_FOR_EXCLUSION>
<P>Did not state randomised. Not assessing analgesic response of DHC</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Myers-1958">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not double blind</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Riethmuller-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised controlled trial. Not double blind. No placebo control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ruch-1957">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised. Single blind</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Seymour-1981">
<CHAR_REASON_FOR_EXCLUSION>
<P>Abstract</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Seymour-1982">
<CHAR_REASON_FOR_EXCLUSION>
<P>Baseline pain not moderate or severe</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Seymour-1983a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Baseline pain not moderate or severe<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Seymour-1983b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Baseline pain not moderate or severe. Not double blind.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sliom-1970">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised. Not double blind. No placebo control; baseline pain not moderate or severe</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Squirrell-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Did not assess analgesic properties of dihydrocodeine. Method of surgery randomised not drug. Drugs administered on demand</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Traykova-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>No placebo group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Walker-1977">
<CHAR_REASON_FOR_EXCLUSION>
<P>No data to extract (non standard PI and PR scales)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Walters-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Abstract</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Walters-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>Baseline pain intensity not moderate or severe</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Williams-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not double blind. No pain outcome data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wotherspoon-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not postoperative pain (cold induced pain). No placebo control (naproxen sodium). Baseline pain not moderate or severe</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Yadav-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not double blind</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Frame-1989">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Galasko-1989">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-McQuay-1985">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-McQuay-1993">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Dihydrocodeine 30 mg versus placebo</NAME>
<DICH_OUTCOME CHI2="5.558311268502498" CI_END="2.504591890422953" CI_START="1.0069791098413594" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.588103180632163" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="19" I2="64.01784816669985" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.3987369700529001" LOG_CI_START="0.0030204610454461654" LOG_EFFECT_SIZE="0.2008787155491731" METHOD="MH" NO="1" P_CHI2="0.06209095752861049" P_Q="0.0" P_Z="0.046603674723758655" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="97" TOTAL_2="97" WEIGHT="100.0" Z="1.9898843681026674">
<NAME>Patients with at least 50% pain relief</NAME>
<GROUP_LABEL_1>Dihydrocodeine 30 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours DHC</GRAPH_LABEL_2>
<DICH_DATA CI_END="18.266306736780916" CI_START="0.9120467182886892" EFFECT_SIZE="4.081632653061225" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.2616507462590512" LOG_CI_START="-0.039982914988116014" LOG_EFFECT_SIZE="0.6108339156354675" ORDER="833" O_E="0.0" SE="0.7645860558071236" STUDY_ID="STD-Frame-1989" TOTAL_1="49" TOTAL_2="50" VAR="0.5845918367346938" WEIGHT="10.214898126902774"/>
<DICH_DATA CI_END="1.6736687005414987" CI_START="0.5974898136509693" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="14" LOG_CI_END="0.22366949441812584" LOG_CI_START="-0.22366949441812584" LOG_EFFECT_SIZE="0.0" ORDER="834" O_E="0.0" SE="0.2627691364061218" STUDY_ID="STD-Galasko-1989" TOTAL_1="30" TOTAL_2="28" VAR="0.06904761904761907" WEIGHT="74.72474738153014"/>
<DICH_DATA CI_END="8.977028752762848" CI_START="0.8826063344469574" EFFECT_SIZE="2.814814814814815" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" LOG_CI_END="0.9531326161989565" LOG_CI_START="-0.05423295995534849" LOG_EFFECT_SIZE="0.449449828121804" ORDER="835" O_E="0.0" SE="0.5917315259730627" STUDY_ID="STD-McQuay-1985" TOTAL_1="18" TOTAL_2="19" VAR="0.35014619883040937" WEIGHT="15.060354491567079"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>Dihydrocodeine 30 mg versus ibuprofen 400 mg</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.5216372682006786" CI_START="0.05325113727704636" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="18" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="-0.2826313881432526" LOG_CI_START="-1.2736711126240345" LOG_EFFECT_SIZE="-0.7781512503836436" METHOD="MH" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.002084820217696083" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0" Z="3.0778754627132545">
<NAME>Patients with at least 50% pain relief</NAME>
<GROUP_LABEL_1>Dihydrocodeine 30 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Ibuprofen 400 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ibuprofen</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours DHC</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.5216372682006785" CI_START="0.05325113727704636" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="18" LOG_CI_END="-0.2826313881432527" LOG_CI_START="-1.2736711126240345" LOG_EFFECT_SIZE="-0.7781512503836436" ORDER="836" O_E="0.0" SE="0.582141639885766" STUDY_ID="STD-McQuay-1993" TOTAL_1="40" TOTAL_2="40" VAR="0.3388888888888888" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>Dihydrocodeine 60 mg versus ibuprofen 400 mg</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.7518384580274446" CI_START="0.1477858839552142" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="18" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="-0.12387546303039494" LOG_CI_START="-0.8303670464089299" LOG_EFFECT_SIZE="-0.4771212547196625" METHOD="MH" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.008114216704000173" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0" Z="2.6472798756841125">
<NAME>Patients with at least 50% pain relief</NAME>
<GROUP_LABEL_1>Dihydrocodeine 60 mg</GROUP_LABEL_1>
<GROUP_LABEL_2>Ibuprofen 400 mg</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ibuprofen</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours DHC</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.7518384580274446" CI_START="0.1477858839552142" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="18" LOG_CI_END="-0.12387546303039494" LOG_CI_START="-0.8303670464089299" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="837" O_E="0.0" SE="0.4149966532662911" STUDY_ID="STD-McQuay-1993" TOTAL_1="40" TOTAL_2="40" VAR="0.17222222222222222" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-05-28 13:58:48 +0100" MODIFIED_BY="Sheena Derry">
<APPENDIX ID="APP-01" MODIFIED="2008-05-28 13:58:48 +0100" MODIFIED_BY="Sheena Derry" NO="1">
<TITLE MODIFIED="2008-05-28 13:58:46 +0100" MODIFIED_BY="Sheena Derry">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-05-28 13:58:48 +0100" MODIFIED_BY="Sheena Derry">
<P>
<B>Search strategy in MEDLINE</B>
<BR/>1. dihydrocodeine [single term MeSH]<BR/>2. dihydrocodeine<BR/>3. 1 OR 2<BR/>4. PAIN, POSTOPERATIVE [single term MeSH]<BR/>5. ((postoperative adj4 pain$) or (post-operative adj4 pain$) or post-operative-pain$ or (post$ NEAR pain$) or (postoperative adj4 analgesi$) or (post-operative adj4 analgesi$) or ("post-operative analgesi$")) [in title, abstract or keywords]<BR/>6. ((post-surgical adj4 pain$) or ("post surgical" adj4 pain$) or (post-surgery adj4 pain$)) [in title, abstract or keywords]<BR/>7. (("pain-relief after surg$") or ("pain following surg$") or ("pain control after")) [in title, abstract or keywords]<BR/>8. (("post surg$" or post-surg$) AND (pain$ or discomfort)) [in title, abstract or keywords]<BR/>9. ((pain$ adj4 "after surg$") or (pain$ adj4 "after operat$") or (pain$ adj4 "follow$ operat$") or (pain$ adj4 follow$ surg$")) [in title, abstract or keywords]<BR/>10. ((analgesi$ adj4 "after surg$") or (analgesi$ adj4 "after operat$") or (analgesi$ adj4 "follow$ operat$") or (analgesi$ adj4 follow$ surg$"))<BR/>11. OR/4-10<BR/>12. randomized controlled trial.pt.<BR/>13. controlled clinical trial.pt.<BR/>14. randomized controlled trials.sh.<BR/>15. random allocation.sh.<BR/>16. double-blind method.sh.<BR/>17. single blind method.sh.<BR/>18. clinical trial.pt.<BR/>19. exp clinical trials/<BR/>20. (clin$ adj25 trial$).ti,ab.<BR/>21. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).ti,ab.<BR/>22. placebos.sh.<BR/>23. placebo$.ti,ab.<BR/>24. random$.ti,ab.<BR/>25. research design.sh.<BR/>26. OR/12-25<BR/>26. 3 AND 11 AND 26</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>